Sentences with phrase «for breast cancer research in»

She's the heart and soul of the No. 1 fundraising team for breast cancer research in the United States.

Tina McDonough is the heart and soul of the No. 1 fundraising team for breast cancer research in the United States.

Not exact matches

The studios put their pink sticky socks on for a class in Point State Park to support Susan G. Komen and breast cancer research.

«Every year, we host a charity golf tournament to raise money for breast cancer research, but that is in addition to numerous other events.»

In 2010, Encanto's KFC restaurants also began supporting the Susan G. Komen Foundation for breast cancer awareness and research, raising $ 15,000 for the organization's annual Race for the Cure fundraising event.

The first event Towne Park attended was Men For The Cure, an exclusive charity event for gentlemen in support of breast cancer research and outreaFor The Cure, an exclusive charity event for gentlemen in support of breast cancer research and outreafor gentlemen in support of breast cancer research and outreach.

In 2009, The American Institute for Cancer Research (a member of the International Agency for Research on Cancer, a part of the World Health Organization) released the largest review of research into lifestyle and breast cancer ever conducted, which reinforced previous findings that women can reduce their risk by maintaining a healthy weight, being physically active, drinking less alcohol, and breastfeeding their chiCancer Research (a member of the International Agency for Research on Cancer, a part of the World Health Organization) released the largest review of research into lifestyle and breast cancer ever conducted, which reinforced previous findings that women can reduce their risk by maintaining a healthy weight, being physically active, drinking less alcohol, and breastfeeding their cResearch (a member of the International Agency for Research on Cancer, a part of the World Health Organization) released the largest review of research into lifestyle and breast cancer ever conducted, which reinforced previous findings that women can reduce their risk by maintaining a healthy weight, being physically active, drinking less alcohol, and breastfeeding their cResearch on Cancer, a part of the World Health Organization) released the largest review of research into lifestyle and breast cancer ever conducted, which reinforced previous findings that women can reduce their risk by maintaining a healthy weight, being physically active, drinking less alcohol, and breastfeeding their chiCancer, a part of the World Health Organization) released the largest review of research into lifestyle and breast cancer ever conducted, which reinforced previous findings that women can reduce their risk by maintaining a healthy weight, being physically active, drinking less alcohol, and breastfeeding their cresearch into lifestyle and breast cancer ever conducted, which reinforced previous findings that women can reduce their risk by maintaining a healthy weight, being physically active, drinking less alcohol, and breastfeeding their chicancer ever conducted, which reinforced previous findings that women can reduce their risk by maintaining a healthy weight, being physically active, drinking less alcohol, and breastfeeding their children.

This particular meta - study reported that breastfeeding provides up to a 28 % decrease in risk of developing breast cancer at any age (pre - or post-menopausal) for women without a family history of the disease, who breastfed for 12 months or longer (World Cancer Research Fund and American Institute for Cancer Research, cancer at any age (pre - or post-menopausal) for women without a family history of the disease, who breastfed for 12 months or longer (World Cancer Research Fund and American Institute for Cancer Research, Cancer Research Fund and American Institute for Cancer Research, Cancer Research, 2007).

Donating money and participating in fundraising walks for breast cancer awareness and research are a passion of mine, so being able to contribute more money to Susan G. Komen through my milk donations is a complete bonus.

In this talk, Natalie presents the latest state of research into the links between breast feeding and breast cancer, including the latest evidence for risk reduction and our understanding of how pregnancy - associated breast cancer develops.

Research has found that women's breast cancer risk declines in inverse proportion to the duration of breastfeeding: That is, the longer you breastfeed your baby, the lower your risk for developing breast cancer.

We held an amazing Breast Cancer Awareness: Fashionable Gals For A Cure Fundraiser & Giveaway on our sister - site, The Fashionable Gal, in October 2009 which raised over $ 500 for Breast Cancer ResearFor A Cure Fundraiser & Giveaway on our sister - site, The Fashionable Gal, in October 2009 which raised over $ 500 for Breast Cancer Researfor Breast Cancer Research.

Ms. Burt chose the Valley breast surgery team after carefully researching her treatment options for DCIS (ductal carcinoma in situ), a diagnosis that is often debated among clinicians as to whether it should be classified as breast cancer at all.

Women with a mental illness (including depression, anxiety and serious mental illnesses) are less likely to be screened for breast cancer, according to new research published in the BJPsych (online first).

This work was supported by the Carney Family Charitable Foundation, the National Cancer Institute's SPORE in Breast Cancer at Dana - Farber / Harvard Cancer Center (grant P50CA168504), STIMIT Corporation, and the Claudia Adams Barr Program for Innovative Cancer Research.

The research team conducted a cross-sectional survey of women who underwent breast cancer surgery for invasive breast cancer or ductal carcinoma in situ at Women & Infants Hospital.

The results for breast cancer are in line with previous research, but the true effect of alcohol on risk of ischaemic heart disease remains uncertain, say the editorial authors.

«This study forms the basis for future research in patients with breast cancer and offers hope for targeted therapy for patients with aggressive triple - negative inflammatory breast cancer,» said lead researcher Mateusz Opyrchal, M.D., Ph.D., Assistant Professor of Oncology at RPCI.

Much like the association between BRCA gene mutation and the risk for breast cancer in women changed the approach to treatment / prevention, the identification of the Kallikrein 6 gene region may change the course of prostate cancer care through a blood test developed by the Lunenfeld - Tanenbaum Research Institute.

These include the ability to bring new, innovative products to the market; progress in oncology, such as the approval of Genentech's drug Avastin for breast cancer and advances in the use of gene therapy, despite some setbacks; continuing progress in research on stem cells; the emergence of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.

The number of breast cancer patients undergoing immediate breast reconstruction operations after mastectomy has grown steadily over the past 15 years, most notably among women who were once considered too high - risk for reconstruction procedures according to new research findings published in the October 2014 issue of the Journal of the American College of Surgeons.

Steven Narod, director of the Familial Breast Cancer Research Unit at Women's College Research Institution in Toronto, believes that cost and not flawed computer programs are to blame for undertesting.

Her research, published in the International Archives of Occupational and Environmental Health, examined key studies that included risk factors for developing breast cancer.

Researchers at the Kaiser Permanente Center for Health Research in Portland, Ore., concluded there is definitely a link between breast cancer and the use of menopausal hormone therapy, particularly estrogen - progestin treatment combinations.

Principal investigator E. Shelley Hwang, M.D., chief of breast surgery at the Duke Cancer Institute and vice chair of research in the Duke University Department of Surgery, will lead the study through the cooperative group, The Alliance for Clinical Trials in Oncology.

Witt - Enderby is on the grant review panel for the Susan G. Komen Breast Cancer charity, which is placing greater emphasis on translational research, and a corresponding increase in suitable bids.

The Susan G. Komen Breast Cancer Foundation, for example, received more than four times its usual number of applications owing to cuts in NIH spending on breast cancer research, according to Paula Witt - Enderby, a researcher at Duquesne University in Pittsburgh and a member of the charity's grant review Breast Cancer Foundation, for example, received more than four times its usual number of applications owing to cuts in NIH spending on breast cancer research, according to Paula Witt - Enderby, a researcher at Duquesne University in Pittsburgh and a member of the charity's grant review Cancer Foundation, for example, received more than four times its usual number of applications owing to cuts in NIH spending on breast cancer research, according to Paula Witt - Enderby, a researcher at Duquesne University in Pittsburgh and a member of the charity's grant review breast cancer research, according to Paula Witt - Enderby, a researcher at Duquesne University in Pittsburgh and a member of the charity's grant review cancer research, according to Paula Witt - Enderby, a researcher at Duquesne University in Pittsburgh and a member of the charity's grant review panel.

«Despite the presence of a universal health insurance system in Ontario, our research highlights the persistence of significant health disparities in breast cancer screening, particularly for women who are more vulnerable due to severe disability, multiple chronic conditions, low income and lower education,» said Dr. Guilcher, who has a PhD in Clinical Epidemiology at the Institute of Health Policy, Management and Evaluation, University of Toronto.

While this is hopeful news for some patients, more research is needed to further understand not only IL13RA2, but other molecules in breast cancers that may guide diagnosis, prognosis, and ultimately drug development and therapy.

«These findings will give women with early stage breast cancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates CommCancer Research Advocates Committee.

A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases.

An enriched hops extract activates a chemical pathway in cells that could help prevent breast cancer, according to new laboratory findings from the UIC / NIH Center for Botanical Dietary Supplements Research at the University of Illinois at Chicago.

Supported by the Basser Research Center for BRCA in Penn's Abramson Cancer Center, Zhang and his team built a DNA copy number profile for nearly 14,000 long non-coding RNA, or lncRNAs, across 12 cancer types, including ovarian and breast cancers — the two major BRCA - related caCancer Center, Zhang and his team built a DNA copy number profile for nearly 14,000 long non-coding RNA, or lncRNAs, across 12 cancer types, including ovarian and breast cancers — the two major BRCA - related cacancer types, including ovarian and breast cancers — the two major BRCA - related cancers.

«I do breast cancer research for my PhD,» tweeted Sarah Hengel, a graduate student at the University of Iowa in Iowa City.

«This research is an important advance in the potential expansion of fertility preservation options for young patients who may not be able to undergo hormone stimulation to induce ovulation before beginning chemotherapy,» says study author Jacqueline S. Jeruss, M.D., Ph.D., associate professor of surgery and director of the Breast Care Center at the University of Michigan Comprehensive Cancer Center.

The application of NGS to breast cancer research has enabled the development of cost - effective, multigene sequencing panels that have advanced our understanding of the disease and may in the future translate into better diagnosis and outcomes for patients.

Dr. Narod, who is also a Tier 1 Canada Research Chair in Breast Cancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian cCancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian cancercancer:

Gerry Potter and Ray McCague of the Institute of Cancer Research in Surrey based their design strategy on tamoxifen, a drug widely used for treating breast cCancer Research in Surrey based their design strategy on tamoxifen, a drug widely used for treating breast cancercancer.

For the study, Dr. Hodgson's research team gathered published information from dozens of studies about the risk of developing breast cancer in childhood lymphoma survivors, the accuracy of different forms of breast cancer screening, and the rates at which women agree to be screened when asked.

In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers — triple negative breast canceIn a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers — triple negative breast cancein animal models in one of the hardest to treat cancers — triple negative breast cancein one of the hardest to treat cancers — triple negative breast cancer.

Professor Jones said: «This analysis of breast density provides a new framework for additional experimental exploration in breast cancer research.

The panel also called for «aggressive research» on using RU486 and other drugs in the antiprogrestin class as contraceptives and as treat - ment for endometriosis, uter - ine fibroids, advanced breast cancer and meningioma brain tumours.

Women with higher breast density — detected on mammograms — have more compacted breast tissue and are more likely to develop breast cancer, but until now the reasons for this have been unclear.Manchester scientists, funded by leading UK research organisation Breakthrough Breast Cancer, worked with IBM researchers and academics in the USA and Cyprus to uncover the biological mechanisms atbreast density — detected on mammograms — have more compacted breast tissue and are more likely to develop breast cancer, but until now the reasons for this have been unclear.Manchester scientists, funded by leading UK research organisation Breakthrough Breast Cancer, worked with IBM researchers and academics in the USA and Cyprus to uncover the biological mechanisms atbreast tissue and are more likely to develop breast cancer, but until now the reasons for this have been unclear.Manchester scientists, funded by leading UK research organisation Breakthrough Breast Cancer, worked with IBM researchers and academics in the USA and Cyprus to uncover the biological mechanisms atbreast cancer, but until now the reasons for this have been unclear.Manchester scientists, funded by leading UK research organisation Breakthrough Breast Cancer, worked with IBM researchers and academics in the USA and Cyprus to uncover the biological mechanisms atcancer, but until now the reasons for this have been unclear.Manchester scientists, funded by leading UK research organisation Breakthrough Breast Cancer, worked with IBM researchers and academics in the USA and Cyprus to uncover the biological mechanisms atBreast Cancer, worked with IBM researchers and academics in the USA and Cyprus to uncover the biological mechanisms atCancer, worked with IBM researchers and academics in the USA and Cyprus to uncover the biological mechanisms at play.

A Supreme Court decision in June to strike down a company's patent on genes linked to breast cancer could have far - reaching consequences for biotechnology and medical research.

Mammary stem cells can give rise to new breast cells during fetal development, adolescence or lactation and may also play a role in breast cancer, so they represent a highly promising avenue for breast cancer research.

New research by scientists at the Pennsylvania Cancer and Regenerative Medicine Research Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breastresearch by scientists at the Pennsylvania Cancer and Regenerative Medicine Research Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breast cCancer and Regenerative Medicine Research Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breastResearch Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breast cancercancer.

Research by the Baruch S. Blumberg Institute's Pennsylvania Cancer and Regenerative Medicine Research Center suggests that the use of HIV drugs can allow for lower doses of chemotherapy in treating breast cancer, reducing side eCancer and Regenerative Medicine Research Center suggests that the use of HIV drugs can allow for lower doses of chemotherapy in treating breast cancer, reducing side ecancer, reducing side effects

Rieger conducted her research in zebrafish exposed to paclitaxel, a chemotherapeutic agent used for ovarian, breast, lung, pancreatic and other cancers.

In breast cancer research, the gene BRCA1 has received the lion's share of attention because mutations in that gene are responsible for about three percent of all cases of breast canceIn breast cancer research, the gene BRCA1 has received the lion's share of attention because mutations in that gene are responsible for about three percent of all cases of breast cancein that gene are responsible for about three percent of all cases of breast cancer.

My translational research has focused on trying to find better ways to estimate recurrence risk in patients diagnosed with oestrogen - receptor positive early breast cancer, with the ultimate aim to better personalise our therapies for those patients who have the most to gain from them.